Stock listing
0A4K Stock Price, News, Filings & Events — Bionano Genomics, Inc.
Selected listing: 0A4K · LSE · USD · GB
This page tracks Bionano Genomics, Inc.'s 0A4K:LSE listing on LSE in USD for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0A4K:LSE. 0A4K:LSE is the stock-level entry point for investors researching Bionano Genomics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bionano Genomics, Inc. (ticker: BNGO) is a public company based in the United States, specializing in genomic analysis technology. The company has a market capitalization of approximately $13.08 million. Bionano focuses on providing innovative solutions for genome mapping and analysis, aiming to enhance research and clinical applications in genomics.
- Ticker
- 0A4K:LSE
- Asset type
- Stock
- Market cap
- $13.8M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSE
- Currency
- USD
Bionano Genomics, Inc. 0A4K:LSE stock context
This page tracks Bionano Genomics, Inc.'s 0A4K:LSE listing on LSE in USD for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0A4K:LSE. 0A4K:LSE is the stock-level entry point for investors researching Bionano Genomics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bionano Genomics, Inc. (ticker: BNGO) is a public company based in the United States, specializing in genomic analysis technology. The company has a market capitalization of approximately $13.08 million. Bionano focuses on providing innovative solutions for genome mapping and analysis, aiming to enhance research and clinical applications in genomics.
Latest news from Bionano Genomics, Inc.
Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
August 24, 2026
Bionano Reports Second Quarter 2026 Results and Provides a Business Update
August 10, 2026
Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026
July 27, 2026
Bionano Announces Hiring of Chief Scientific Officer
June 24, 2026
Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption
June 18, 2026
Bionano Genomics, Inc. earnings calls
Bionano Genomics, Inc. (BNGO) Q2 2026 Earnings Call
August 10, 2026 · Replay with transcript and chapters
Bionano Genomics, Inc. (BNGO) Q1 2026 Earnings Call
May 13, 2026 · Replay with transcript and chapters
Bionano Genomics, Inc. (BNGO) Q4 2025 Earnings Call
March 23, 2026 · Replay with transcript and chapters
Bionano Genomics, Inc. (BNGO) Q3 2025 Earnings Call
November 13, 2025 · Replay with transcript and chapters
Bionano Genomics, Inc. (BNGO) Q2 2025 Earnings Call
August 14, 2025 · Replay with transcript and chapters
Bionano Genomics, Inc. (BNGO) Q1 2025 Earnings Call
May 14, 2025 · Replay with transcript and chapters
Research Bionano Genomics, Inc.
Bionano Genomics, Inc. investor report
Review AI stock analysis and investor report context for 0A4K:LSE.
Bionano Genomics, Inc. company profile
View the public company page for Bionano Genomics, Inc. on 6ix.
Bionano Genomics, Inc. news
Read company news and market updates connected to Bionano Genomics, Inc..
Bionano Genomics, Inc. investor events
Find investor webinars, events, and replay context for Bionano Genomics, Inc..
Alternate listings
BNGO:NASDAQ
US · USD
Alternate listing for Bionano Genomics, Inc.; the primary context on this page is 0A4K:LSE.
BNGO:BMV
MX · MXN
Alternate listing for Bionano Genomics, Inc.; the primary context on this page is 0A4K:LSE.
BNGO:BIVA
MX · MXN
Alternate listing for Bionano Genomics, Inc.; the primary context on this page is 0A4K:LSE.
BNGO:BOATS
US · USD
Alternate listing for Bionano Genomics, Inc.; the primary context on this page is 0A4K:LSE.
2Y3:GETTEX
DE · EUR
Alternate listing for Bionano Genomics, Inc.; the primary context on this page is 0A4K:LSE.